Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chloroquine as a prophylactic agent against COVID-19?
Gendrot M, Javelle E, Clerc A, Savini H, Pradines B. Gendrot M, et al. Among authors: javelle e. Int J Antimicrob Agents. 2020 Jun;55(6):105980. doi: 10.1016/j.ijantimicag.2020.105980. Epub 2020 Apr 12. Int J Antimicrob Agents. 2020. PMID: 32294495 Free PMC article.
Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates.
Foguim FT, Bogreau H, Gendrot M, Mosnier J, Fonta I, Benoit N, Amalvict R, Madamet M, Wein S, Pradines B; French National Reference Centre for Imported Malaria Study Group. Foguim FT, et al. Malar J. 2020 Jun 5;19(1):201. doi: 10.1186/s12936-020-03281-x. Malar J. 2020. PMID: 32503540 Free PMC article.
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]).
Carvelli J, Meziani F, Dellamonica J, Cordier PY, Allardet-Servent J, Fraisse M, Velly L, Barbar SD, Lehingue S, Guervilly C, Desgrouas M, Camou F, Piperoglou C, Vely F, Demaria O, Karakunnel J, Fares J, Batista L, Rotolo F, Viotti J, Boyer-Chammard A, Lacombe K, Le Dault E, Carles M, Schleinitz N, Vivier E; FOR COVID Elimination (FORCE) Study Group. Carvelli J, et al. Crit Care Med. 2022 Dec 1;50(12):1788-1798. doi: 10.1097/CCM.0000000000005683. Epub 2022 Oct 10. Crit Care Med. 2022. PMID: 36218354 Free PMC article. Clinical Trial.
The challenge of chronic chikungunya.
Javelle E, Gautret P, Ribéra A, Gaüzère BA, Cabié A, Corail PR, Simon F. Javelle E, et al. Travel Med Infect Dis. 2017 Jan-Feb;15:3-4. doi: 10.1016/j.tmaid.2017.02.002. Epub 2017 Feb 9. Travel Med Infect Dis. 2017. PMID: 28189872 No abstract available.
Business travel-associated illness: a GeoSentinel analysis.
Chen LH, Leder K, Barbre KA, Schlagenhauf P, Libman M, Keystone J, Mendelson M, Gautret P, Schwartz E, Shaw M, MacDonald S, McCarthy A, Connor BA, Esposito DH, Hamer D, Wilson ME; GeoSentinel Surveillance Network. Chen LH, et al. J Travel Med. 2018 Jan 1;25(1):10.1093/jtm/tax097. doi: 10.1093/jtm/tax097. J Travel Med. 2018. PMID: 29462444 Free PMC article.
70 results